Zydus Nesher Pharmaceuticals receives USFDA final approval for Omega-3-Acid Ethyl Esters Capsules

Zydus Nesher Pharmaceuticals receives USFDA final approval for Omega-3-Acid Ethyl Esters Capsules

Jun 14, 2019 06:06 IST capital market

Zydus Nesher Pharmaceuticals, a subsidiary of Zydus Pharmaceuticals USA has received the final approval from the USFDA to market Omega-3-Acid Ethyl Esters Capsules USP (US RLD �Lovaza Capsules), 1 gram. Omega-3 acid ethyl esters, a type of fat found in fish oil, is used along with diet and exercise to help lower levels of a certain blood fat (triglyceride). It may also raise good cholesterol(HDL).The drug will be manufactured at Nesher Pharmaceuticals manufacturing facility located at St. Louis, MO, USA.

Related Story